Improving Hairdressers' Knowledge and Self-efficacy to Detect Scalp and Neck Melanoma by Use of an Educational Video
Half of melanomas go undetected by self-inspection, and those undetected occur frequently on the scalp and neck (S-N). 1 We have previously provided a rationale for the role of hairdressers, a group that makes daily observations of the scalp and neck, in the detection of S-N melanomas in the general population.
2 Furthermore, in a previous study, we examined melanoma knowledge in 108 hairdressers from 45 hair salons.
3
Results uncovered room for improvement in knowledge regarding signs and symptoms of melanoma, which are standardized in the ABCDE criteria (Asymmetry, irregular Borders, >1 Color, >6 mm in Diameter; Elevation) for atypical nevi and melanoma detection. 4 Most hairdressers desired to learn more about melanoma detection, which is a finding replicated from a Texas sample. 5 In the current study, we now address a major gap in previous research by developing and then testing the efficacy of a video intervention aimed at increasing hairdresser knowledge of melanoma and self-confidence in skin lesion detection.
Methods | We conducted a single-group, pretest-posttest intervention study to assess changes in the scores of hairdressers' self-confidence and knowledge of melanoma detection after an online, 5-minute video (https://vimeo.com/142284021) during 2015. A study link was sent to 20 beauty schools in Los Angeles County by our collaborator, Eyes on Cancer. Questionnaire items were informed by the American Cancer Society Facts and Figures 2013 report. 6 Participants received a $5 gift card and provided informed consent to participate in the study by clicking on the "agree" link provided on the study introduction form. Study protocols gained approval from the University of Southern California institutional review board. Data analyses were conducted using SPSS statistical software (version 21; IBM Corp). Frequencies were examined to determine the percentage of participants who provided correct responses to questionnaire items before and after watching the educational video. The McNemar χ 2 test was used to compare the proportions of participants who provided correct responses to questionnaire items prior to watching the video vs after watching the video. The Wilcoxon signed-rank test was used to examine the difference in confidence in the ability to identify a skin lesion that could potentially be a skin cancer prior to and after watching the video. Statistical testing was set at P < .05 for the analytic sample.
Results | A total of 113 participants enrolled in the study by completing the prevideo questionnaire. A response rate was not established owing to the listserv mailing of the survey link to beauty school administrators. Thirteen participants who did not complete the postvideo questionnaire were excluded from the final analytic sample (n = 100). No 21
How often clients ask for scalp or skin lesion examination
Rarely 81
A few times a year 9
A few times a month 2
A few times a week 4
Daily 4 a Race/ethnicity was not assessed.
Gains were observed for all knowledge of melanoma risk items. Statistically significant gains were observed for correct identification of ABCDE criteria for atypical nevi and melanoma detection (59% vs 71%; P = .008). The proportion of participants reporting "very confident" self-efficacy to detect skin lesion that could potentially be a skin cancer more than doubled following the video (19% vs 41%; P = .001).
Discussion | Hairdressers have the ability to monitor a large extent of the general public's scalp and neck, highlighting their usefulness for the detection of S-N melanomas via populationbased screening and dermatologic referral. Findings from this study suggest that a brief educational video can be beneficial for educating hairdressers about melanoma risk and the ABCDE criteria for atypical nevi and melanoma detection while also building on self-efficacy skills in skin lesion detection that might carry over to improved screening of those individuals at risk for melanoma. Limitations of this study include a small sample size that might have had an effect on our ability to detect changes after education in some of the measures shown in Table 2 , and limited external validity of findings given the convenience sampling approach. Also, 79% of the sample reported some previous training about skin cancer, so in future work, it will be important to know if our educational video functioned to reinforce existing knowledge or to provide new knowledge about melanoma detection, or both. More research is needed to determine if such knowledge and selfefficacy gains are maintained over longer periods of time and against an active control condition in a randomized controlled trial. Based on our initial testing of an educational video intervention, training hairdressers in melanoma screening and referral seems to be a promising avenue for future research. Abbreviations: c, correct response; i, incorrect response. a P < .05 threshold met for McNemar χ 2 test (used to compare the proportions of participants who provided correct responses with questionnaire items prior to watching the video vs after watching the video) and Wilcoxon signed-rank test (used to examine the difference in confidence in the ability to identify a skin lesion that could potentially be a skin cancer prior to and after watching the video). Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. 
Management of Morgellons Disease With Low-Dose Trifluoperazine
Morgellons disease is a poorly understood condition characterized by delusions of cutaneous infiltration by microbes and/or inanimate materials. Current management involves building a strong therapeutic alliance, treating cutaneous lesions, and using low-dose antipsychotics. 1-3 Our study examines the novel use of low-dose trifluoperazine, a highpotency typical antipsychotic, in this patient population.
Methods | This is a Weill Cornell Medical College institutional review board-approved retrospective medical record review of adult patients with Morgellons disease who presented to our dermatology department between September 1, 2006, to August 31, 2016. Inclusion criteria included age 18 years or older and at least 2 visits with a single investigator (J.L.J.). Patients with clinicopathological evidence of another dermatologic process were excluded. The main outcomes examined were clinical response, time to remission, and adverse effects. Partial remission was defined as patient-reported improvement, and at least 50% lesion clearance as determined by the same physician. Baseline function was defined as at least 90% lesion clearance and no patient-reported distress from perceived skin infiltrates.
Patients received empathetic counseling concordant with published recommendations, 3 including using formication as a dermatologic sign. Trifluoperazine was initiated at 1 mg/d at bedtime, with uptitration of 1 mg/d every month according to the clinical picture. Patients were assessed for extrapyramidal findings and mood changes during follow-up visits.
Results | Twenty-four patients met inclusion criteria ( Table 1) . Four patients were excluded; Table 2 provides a clinical overview. The mean (range) follow-up time was 11.2 (0.9-39.8) months. With our management approach, 7 patients (29%) returned to baseline function. Fifteen patients (63%) achieved at least 50% improvement. The average dosage for 50% to 90% and at least 90% improvement was 1.9 mg/d and 2.3 mg/d, respectively. Four patients (17%) reported minor adverse effects, with the most common being drowsiness (2 patients), which resolved with time.
The mean (range) time to at least 50% and 90% disease control was 2.4 (0.9-5.0) months and 6.6 (3.2-13.1) months, respectively. Of patients who achieved baseline function, all had median dosages of 2 mg/d and remained in remission at their last visit, with a mean (range) remission time of 10.0 (3.0-18.2) months.
When comparing patients receiving median dosages of 1 mg/d and 2 mg/d, the median time to partial remission for both groups was 2.1 months, with a median (interquartile range [IQR] ) duration of response of 2.3 (1.9-2.6) months and 4.7 (2.9-12.6) months, respectively. Of patients with median dosages of 1 mg/d, 50% achieved partial responses. Among patients with median dosages of 2 mg/d, 10 (71%) achieved at least partial responses and 7 (50%) achieved baseline function, with a median (IQR) duration of remission of 9.9 (3.7-15.4) months.
Discussion | Research on antipsychotic therapies for Morgellons disease remains limited. Pimozide, a typical antipsychotic, was historically favored, partly because of its antipruritic properties.
1 Nowadays, as with other medications, the decision between pimozide and other antipsychotics involves considering their efficacy and profiles of adverse effects.
1,4
Our findings, with 63% of patients achieving partial or full remission, are concordant with published results using pimozide and atypical antipsychotics, although direct comparisons are difficult owing to heterogeneity of the studies. Moreover, our finding that a higher dosage of trifluoperazine is associated with a longer duration of response and a greater percentage of patients achieving remission suggests a positive dose-response relationship.
Similar to the antipruritic effects of pimozide, low-dose trifluoperazine has analgesic effects from its opioidreceptor system interactions.
5 Moreover, consistent with our observations, trifluoperazine at low dosages up to 4 mg/d has limited to no adverse effects. 6 Given the comparative safety, cost-effectiveness, and clinical efficacy, we propose the use of low-dose trifluoperazine for Morgellons 
